Techne Corp.
614 McKinley Place NE
Minneapolis,
MN 55413
Phone: 612-379-8854
Fax: 612-379-6580
Web Site: http://www.techne-corp.com
| REUTERS ABRIDGED BUSINESS SUMMARY | |
| TECHNE Corporation develops and manufactures biotechnology products and hematology calibrators and controls. The company offers biotechnology products that include cytokines, which are extracted from natural sources or produced using recombinant DNA technology; enzymes and related factors, including enzyme substrates and inhibitors; antibodies that are proteins produced by the immune system of an animal that specifically recognize and bind to target molecules; assay kits that include human and animal quantikine kits, which enable research scientists to quantify the amount of a specific analyte in a sample of serum or other biological fluids; clinical diagnostic kits, which comprise erythropoietin, transferrin receptor, and Beta2-microglobulin immunoassay diagnostic kits; flow cytometry products, which include antibodies and fluorokine kits that are used to measure the presence or absence of cell surface receptors for specific cytokines by flow cytometry; and intracellular cell signaling products, which provide reagents to study apoptosis and to elucidate signal transduction pathways. It also offers hematology products, including whole blood CBC controls/calibrators; linearity and reportable range controls that provide a means of assessing the linearity of hematology analyzers for white blood cells, red blood cells, platelets, and reticulocytes; whole blood reticulocyte controls designed for manual and automated counting of reticulocytes; whole blood flow cytometry controls, which are controls for flow cytometry instruments; whole blood glucose/hemoglobin controls designed to monitor instruments which measure glucose and hemoglobin in whole blood; erythrocyte sedimentation rate controls designed to monitor erythrocyte sedimentation rate tests; and multi-purpose platelet reference controls designed for use by automated and semi-automated analyzers which monitor platelet levels. The company was founded in 1976 and is based in Minneapolis, Minnesota. |
|
| Key Statistics | More from Reuters
Expanded Business Description |
| |
| REUTERS ABRIDGED FINANCIAL SUMMARY | |
| | Pay | Exercised | Mr. Thomas E. Oland , 67
Chairman, Chief Exec. Officer, Pres and Treasurer |
N/A
| N/A | Mr. Gregory J. Melsen , 55
Chief Financial Officer and VP of Fin. |
N/A
| N/A | Mr. Marcel Veronneau , 54
VP of Hematology Operations |
N/A
| N/A | Kathy Backes ,
Chief Accounting Officer and Controller |
N/A
| N/A | Dr. Richard A. Krzyzek Ph.D.,
VP of Research |
N/A
| N/A |
|
|
|
Dollar amounts are as of
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.01 (0.02%)
Reuters offers more in-depth
